http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004516311-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2001-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2004-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2004516311-A
titleOfInvention Atorvastatin crystal
abstract The present invention relates to novel crystalline forms of atorvastatin calcium (2: 1), designated herein as polymorphic forms X, A, B1, B2, C, D and E. Furthermore, the present invention relates to a method for producing these crystals, and a pharmaceutical composition containing these crystals.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008007507-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008534669-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012031130-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018008569-A1
priorityDate 2000-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454027302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86619959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448286351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86621612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448850249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21941165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453717219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426248706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447730362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451010808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093208
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6483036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426114673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467358165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67228572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467358516

Total number of triples: 61.